Limited Competition for the Continuation of the Intestinal Stem Cell Consortium Research Centers (U01 Clinical Trial Not Allowed)

0
71

Funding Opportunity ID:309145
Opportunity Number:RFA-DK-18-507
Opportunity Title:Limited Competition for the Continuation of the Intestinal Stem Cell Consortium Research Centers (U01 Clinical Trial Not Allowed)
Opportunity Category:Discretionary
Opportunity Category Explanation:
Funding Instrument Type:Cooperative Agreement
Category of Funding Activity:Food and Nutrition
Health
Category Explanation:
CFDA Number(s):93.847
93.855
Eligible Applicants:Public and State controlled institutions of higher education
Additional Information on Eligibility:Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. see the funding announcement for eligibility details
Agency Code:HHS-NIH11
Agency Name:Department of Health and Human Services
National Institutes of Health
Posted Date:Sep 21, 2018
Close Date:Nov 21, 2018
Last Updated Date:Sep 21, 2018
Award Ceiling:$250,000
Award Floor:$0
Estimated Total Program Funding:
Expected Number of Awards:
Description:This Limited Competition Funding Opportunity Announcement (FOA) invites applications from the Program Directors/Principal Investigators of the nine current Research Centers (RCs) of the Intestinal Stem Cell Consortium (ISCC) to submit collaborative projects to characterize the minimal, required niche factors that support intestinal stem cells in health and disease, using an integrated, multidisciplinary team science approach. The nine current RCs have been collaborating for the past 4 years, answering major questions in stem cell biology of the intestinal epithelium and also accelerating research by making information and resources available to the research community. In addition, the RCs have established effective and proficient collaborations with other RCs within the ISCC. The primary objective of this FOA is to continue advancing the understanding of intestinal epithelial stem cell biology with the ultimate goal of developing novel therapies targeting intestinal stem cells and supportive niche to regenerate and rebuild the human intestine.
Version:1





Visit the Official Webpage For More Details on Limited Competition for the Continuation of the Intestinal Stem Cell Consortium Research Centers (U01 Clinical Trial Not Allowed)